NO20054085L - Substituerte heksahydropyrazino [1,2-a]pyrimidin-4,7-dionderivater, fremgangsmater for fremstilling og anvendelse derav som medikamenter - Google Patents

Substituerte heksahydropyrazino [1,2-a]pyrimidin-4,7-dionderivater, fremgangsmater for fremstilling og anvendelse derav som medikamenter

Info

Publication number: NO20054085L
Authority: NO; Norway
Prior art keywords: pyrimidine; preparation; medicaments; methods; dione derivatives
Prior art date: 2003-02-13

Application number

NO20054085A

Other languages

English (en)

Norwegian (no)

Inventor

Matthias Gossel

Thomas Klabunde

Siegfried Stengelin

Stefanie Flohr

Original Assignee

Aventis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-02-13

Filing date

2005-09-02

Publication date

2005-09-02

2003-02-13 Priority claimed from DE10305885A external-priority patent/DE10305885A1/de

2003-10-24 Priority claimed from DE10349672A external-priority patent/DE10349672A1/de

2005-09-02 Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh

2005-09-02 Publication of NO20054085L publication Critical patent/NO20054085L/no

Links

CYCRMTFRHLQFIV-UHFFFAOYSA-N 2,3,6,8,9,9a-hexahydro-1h-pyrazino[1,2-a]pyrimidine-4,7-dione Chemical class N1CCC(=O)N2C1CNC(=O)C2 CYCRMTFRHLQFIV-UHFFFAOYSA-N 0.000 title abstract 2
239000003814 drug Substances 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
229940125709 anorectic agent Drugs 0.000 abstract 1
239000002830 appetite depressant Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Dermatology (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Child & Adolescent Psychology (AREA)
Emergency Medicine (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Addiction (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)

NO20054085A 2003-02-13 2005-09-02 Substituerte heksahydropyrazino [1,2-a]pyrimidin-4,7-dionderivater, fremgangsmater for fremstilling og anvendelse derav som medikamenter NO20054085L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10305885A DE10305885A1 (de)	2003-02-13	2003-02-13	Substituierte Hexahydro-pyrazino(1,2-a)pyrimidin-4,7-dionderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10349672A DE10349672A1 (de)	2003-10-24	2003-10-24	Substituierte Hexahydro-pyrazino(1,2-a)pyrimidin-4,7-dionderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
PCT/EP2004/000769 WO2004072076A1 (fr)	2003-02-13	2004-01-29	Derives de hexahydro-pyrazino(1,2-a)pyrimidine-4,7-diones substitues, procedes de fabrication et utilisation en tant qu'agents pharmaceutiques

Publications (1)

Publication Number	Publication Date
NO20054085L true NO20054085L (no)	2005-09-02

Family

ID=32870334

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20054085A NO20054085L (no)	2003-02-13	2005-09-02	Substituerte heksahydropyrazino [1,2-a]pyrimidin-4,7-dionderivater, fremgangsmater for fremstilling og anvendelse derav som medikamenter

Country Status (21)

Country	Link
EP (1)	EP1599480B1 (fr)
JP (1)	JP2006517550A (fr)
KR (1)	KR20050111588A (fr)
AR (1)	AR043155A1 (fr)
AT (1)	ATE472548T1 (fr)
AU (1)	AU2004212042A1 (fr)
BR (1)	BRPI0407507A (fr)
CA (1)	CA2515735A1 (fr)
CO (1)	CO5690597A2 (fr)
DE (1)	DE502004011328D1 (fr)
HR (1)	HRP20050712A2 (fr)
MA (1)	MA27654A1 (fr)
MX (1)	MXPA05007516A (fr)
MY (1)	MY135902A (fr)
NO (1)	NO20054085L (fr)
PE (1)	PE20050192A1 (fr)
PL (1)	PL377227A1 (fr)
RS (1)	RS20050564A (fr)
RU (1)	RU2005128497A (fr)
TW (1)	TW200508235A (fr)
WO (1)	WO2004072076A1 (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7566711B2 (en)	2001-10-12	2009-07-28	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
US8080657B2 (en)	2001-10-12	2011-12-20	Choongwae Pharma Corporation	Compounds of reverse turn mimetics and the use thereof
US20040072831A1 (en) *	2001-10-12	2004-04-15	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
US7232822B2 (en)	2001-10-12	2007-06-19	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
US7576084B2 (en)	2001-10-12	2009-08-18	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
US7671054B1 (en)	2001-10-12	2010-03-02	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
RU2005128499A (ru) *	2003-02-13	2006-01-27	Санофи-Авентис Дойчланд Гмбх (De)	Замещенные у азота производные гексагидропиразино (1,2-а) пиримидин-4, 7-диона, способ их получения и их применение в качестве лекарственного средства
DE102004042441A1 (de) *	2004-08-31	2006-04-06	Sanofi-Aventis Deutschland Gmbh	Mit Aminosäuren substituierte Hexahydro-pyrazino(1,2-a)pyrimidin-4,7-dionderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
NZ564759A (en)	2005-06-30	2011-08-26	Prosidion Ltd	GPCR agonists
US20080009500A1 (en) *	2005-11-08	2008-01-10	Michael Kahn	Alpha-helix mimetics and methods relating to the treatment of fibrotic disorders
JP5536336B2 (ja) *	2005-11-08	2014-07-02	チョンウェファーマコーポレイション	α−ヘリックス類似体および癌幹細胞の治療に関する方法
BRPI0715160A2 (pt)	2006-08-08	2013-06-11	Sanofi Aventis	imidazolidina-2,4-dionas substituÍdas por arilamimoaril-alquil-, processo para preparÁ-las, medicamentos compeendendo estes compostos, e seu uso
WO2008081208A1 (fr)	2007-01-04	2008-07-10	Prosidion Limited	Agonistes de gpcr pipéridiniques
AR064736A1 (es)	2007-01-04	2009-04-22	Prosidion Ltd	Agonistas de gpcr
CL2008000018A1 (es)	2007-01-04	2008-08-01	Prosidion Ltd	Compuestos derivados de heterociclos de nitrogeno y oxigeno, agonistas de gpcr; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la obesidad, diabetes, sindrome metabolico, hiperlipidemia, toleranci
BRPI0806498A2 (pt)	2007-01-04	2014-04-22	Prosidion Ltd	Agonistas gpcr piperidina
GB0700122D0 (en)	2007-01-04	2007-02-14	Prosidion Ltd	GPCR agonists
EP2025674A1 (fr)	2007-08-15	2009-02-18	sanofi-aventis	Tetrahydronaphthaline substituée, son procédé de fabrication et son utilisation en tant que médicament
GB0720389D0 (en)	2007-10-18	2008-11-12	Prosidion Ltd	G-Protein Coupled Receptor Agonists
GB0720390D0 (en)	2007-10-18	2007-11-28	Prosidion Ltd	G-Protein coupled receptor agonists
WO2010003624A2 (fr)	2008-07-09	2010-01-14	Sanofi-Aventis	Composés hétérocycliques, leurs procédés de préparation, médicaments comprenant lesdits composés et leur utilisation
WO2010068601A1 (fr)	2008-12-08	2010-06-17	Sanofi-Aventis	Hydrate de fluoroglycoside hétéroaromatique cristallin, ses procédés de fabrication, ses procédés d'utilisation et compositions pharmaceutiques le contenant
DK2470552T3 (en)	2009-08-26	2014-02-17	Sanofi Sa	NOVEL, CRYSTALLINE, heteroaromatic FLUORGLYCOSIDHYDRATER, MEDICINES COVERING THESE COMPOUNDS AND THEIR USE
EP2766349B1 (fr)	2011-03-08	2016-06-01	Sanofi	Dérivés d'oxathiazine substitués par des carbocycles ou des hétérocycles, leur procédé de préparation, médicaments contenant ces composés et leur utilisation
WO2012120050A1 (fr)	2011-03-08	2012-09-13	Sanofi	Nouveaux dérivés phényl-oxathiazine substitués, procédé pour leur préparation, médicaments contenant ces composés et leur utilisation
US8710050B2 (en)	2011-03-08	2014-04-29	Sanofi	Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120054A1 (fr)	2011-03-08	2012-09-13	Sanofi	Dérivés oxathiazine di- et tri-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation
US8809325B2 (en)	2011-03-08	2014-08-19	Sanofi	Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
WO2012120056A1 (fr)	2011-03-08	2012-09-13	Sanofi	Dérivés oxathiazine tétra-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation
EP2683703B1 (fr)	2011-03-08	2015-05-27	Sanofi	Nouveaux dérivés phényl-oxathiazine substitués, procédé pour leur préparation, agent pharmaceutique contenant ces composés et leur utilisation
EP2683704B1 (fr)	2011-03-08	2014-12-17	Sanofi	Dérivés oxathiazine ramifiés, procédé pour leur préparation, utilisation en tant que médicament, agents pharmaceutiques contenant ces dérivés et leur utilisation
WO2012120058A1 (fr)	2011-03-08	2012-09-13	Sanofi	Dérivés d'oxathiazine substitués par des groupes benzyle ou hétérométhylène, leur procédé de production, leur utilisation comme médicament ainsi que produits pharmaceutiques les contenant et leur utilisation
WO2024217497A1 (fr) *	2023-04-21	2024-10-24	The University Of Hong Kong	Nouveaux agonistes à petites molécules du récepteur de l'insuline (insr) utilisés en tant que médicaments anti-diabète

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6184223B1 (en) *	1995-10-27	2001-02-06	Molecumetics Ltd.	Reverse-turn mimetics and methods relating thereto
JP3514774B2 (ja) *	1997-06-25	2004-03-31	ファイザー・インク	成長ホルモン分泌促進薬としてのジペプチド誘導体
US6294525B1 (en) *	1999-09-01	2001-09-25	Molecumetics Ltd.	Reverse-turn mimetics and methods relating thereto
RU2005128499A (ru) *	2003-02-13	2006-01-27	Санофи-Авентис Дойчланд Гмбх (De)	Замещенные у азота производные гексагидропиразино (1,2-а) пиримидин-4, 7-диона, способ их получения и их применение в качестве лекарственного средства

2004
- 2004-01-29 KR KR1020057014859A patent/KR20050111588A/ko not_active Withdrawn
- 2004-01-29 MX MXPA05007516A patent/MXPA05007516A/es not_active Application Discontinuation
- 2004-01-29 AT AT04706170T patent/ATE472548T1/de not_active IP Right Cessation
- 2004-01-29 EP EP04706170A patent/EP1599480B1/fr not_active Expired - Lifetime
- 2004-01-29 JP JP2006501649A patent/JP2006517550A/ja active Pending
- 2004-01-29 WO PCT/EP2004/000769 patent/WO2004072076A1/fr not_active Ceased
- 2004-01-29 HR HR20050712A patent/HRP20050712A2/xx not_active Application Discontinuation
- 2004-01-29 CA CA002515735A patent/CA2515735A1/fr not_active Abandoned
- 2004-01-29 BR BRPI0407507-2A patent/BRPI0407507A/pt not_active IP Right Cessation
- 2004-01-29 PL PL377227A patent/PL377227A1/pl not_active Application Discontinuation
- 2004-01-29 AU AU2004212042A patent/AU2004212042A1/en not_active Abandoned
- 2004-01-29 DE DE502004011328T patent/DE502004011328D1/de not_active Expired - Lifetime
- 2004-01-29 RS YUP-2005/0564A patent/RS20050564A/sr unknown
- 2004-01-29 RU RU2005128497/04A patent/RU2005128497A/ru not_active Application Discontinuation
- 2004-02-09 PE PE2004000147A patent/PE20050192A1/es not_active Application Discontinuation
- 2004-02-11 TW TW093103121A patent/TW200508235A/zh unknown
- 2004-02-11 AR ARP040100427A patent/AR043155A1/es unknown
- 2004-02-12 MY MYPI20040456A patent/MY135902A/en unknown
2005
- 2005-08-11 CO CO05079789A patent/CO5690597A2/es not_active Application Discontinuation
- 2005-08-11 MA MA28428A patent/MA27654A1/fr unknown
- 2005-09-02 NO NO20054085A patent/NO20054085L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
DE502004011328D1 (de)	2010-08-12
PL377227A1 (pl)	2006-01-23
CO5690597A2 (es)	2006-10-31
ATE472548T1 (de)	2010-07-15
TW200508235A (en)	2005-03-01
WO2004072076A1 (fr)	2004-08-26
RS20050564A (sr)	2007-09-21
EP1599480B1 (fr)	2010-06-30
KR20050111588A (ko)	2005-11-25
AU2004212042A1 (en)	2004-08-26
PE20050192A1 (es)	2005-04-01
BRPI0407507A (pt)	2006-02-14
CA2515735A1 (fr)	2004-08-26
JP2006517550A (ja)	2006-07-27
RU2005128497A (ru)	2006-01-27
MXPA05007516A (es)	2006-01-27
AR043155A1 (es)	2005-07-20
HRP20050712A2 (en)	2006-09-30
EP1599480A1 (fr)	2005-11-30
MA27654A1 (fr)	2005-12-01
MY135902A (en)	2008-07-31

Legal Events

Date	Code	Title	Description
2009-08-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20054208L (no)	2005-09-09	Nitrogen-substituerte heksahydropyrazino[1,2-a]pyrimidin-4,7-dionderivater, fremgangsmater for fremstilling og anvendelse derav som medikamenter
TW200508235A (en)	2005-03-01	Substituted hexahydropyrazino[1, 2-a]pyrimidine-4, 7-dione derivatives, processes for their preparation and their use as medicaments
TNSN05194A1 (en)	2007-06-11	Substituted n-arylheterocycles, method for production and use thereof as medicaments
MX337817B (es)	2011-11-04	Pirazolo [1,5-a] pirimidinas de utilidad como inhibidores de proteina quinasas.
MX2010006748A (es)	2010-08-18	Pirazolo[1,5-a]pirimidinas utiles como inhibidores de jak2.
TW200606162A (en)	2006-02-16	Pyrazolopyridine derivatives
NO20054905L (no)	2006-01-25	2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
ES2195785A1 (es)	2003-12-01	Nuevos derivados de piridazin-3(2h)-ona.
EP1633740A4 (fr)	2008-11-19	Composes chimiques
BRPI0510560A (pt)	2007-11-20	pirido[2,3-d] pirimidin-7-onas pirrolil substituìdas e seus derivados como agentes terapêuticos
NO20055649L (no)	2006-01-31	Substituert dihydrokinazolin med antiviale egenskaper
TW200613305A (en)	2006-05-01	Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
NO20056032L (no)	2006-02-15	Nye pyridopyraziner og anvendelse derav som kinasemodulatorer
NO20072089L (no)	2007-06-15	Benzimidazolderivater, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav
CY1109366T1 (el)	2014-07-02	Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
TW200505880A (en)	2005-02-16	Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals
UA83821C2 (ru)	2008-08-26	Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
MXPA05013050A (es)	2006-03-02	Derivados de bencimidazol, composiciones que los contienen preparacion de los mismos y usos de los mismos.
NO20053809L (no)	2005-10-17	Diarylmetylindenpiperidinderivater,fremgangsmate for fremstilling derav, og anvendelse derav
PL1869038T3 (pl)	2009-12-31	Podstawione pochodne 5,6,7,8-tetrahydro-imidazo[1,2-a]pirydyn-2-yloaminy i ich zastosowanie do wytwarzania środków leczniczych
BRPI0513287A (pt)	2008-05-06	derivados de pirido-pirimidina, sua preparação, sua aplicação em terapêutica
TW200510399A (en)	2005-03-16	1, 3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups; processes for their preparation and their use as pharmaceuticals
NO20063619L (no)	2006-10-09	Diarylmetylpiperazinderivater, fremstilling og anvendelse derav
WO2006071564A3 (fr)	2007-04-12	Sels amines de 1,2,3-triazoles utilises comme promedicaments comprenant des agents antiviraux
NO20053805L (no)	2005-10-17	Diarylmetylindenpiperidinderivater, framgangsmate for fremstilling derav, og anvendelse derav